LONZA BIOLOGICS PLC
Get an alert when LONZA BIOLOGICS PLC files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£3.3M
+19.7% vs 2023
Net assets
£167M
+2.1% vs 2023
Employees
1,389
-2.1% vs 2023
Profit before tax
£45M
+2.8% vs 2023
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Annual accounts overdue
Due 2026-06-30.
Net assets
2-year trend · vs Consumer Discretionary median
Accounts
2-year trend · Δ = latest vs prior filed period · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | Δ vs prior |
|---|---|---|---|---|
| Turnover | £310,506,000 | £266,962,000 | -14% | |
| Operating profit | £45,839,000 | £45,728,000 | -0.2% | |
| Profit before tax | £43,358,000 | £44,567,000 | +2.8% | |
| Net profit | £28,701,000 | £29,320,000 | +2.2% | |
| Cash | £2,776,000 | £3,322,000 | +19.7% | |
| Total assets less current liabilities | £209,167,000 | £216,931,000 | +3.7% | |
| Net assets | £163,769,000 | £167,179,000 | +2.1% | |
| Equity | £163,769,000 | £167,179,000 | +2.1% | |
| Average employees | 1,419 | 1,389 | -2.1% | |
| Wages | £93,685,000 | £92,313,000 | -1.5% | |
| Directors' remuneration | £792,000 | £629,000 | -20.6% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 14.8% | 17.1% | |
| Net margin | 9.2% | 11.0% | |
| Return on capital employed | 21.9% | 21.1% | |
| Current ratio | 1.37x | 1.72x | |
| Interest cover | 6.59x | 7.39x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- LONZA BIOLOGICS PLC 1996-07-01 → present
- CELLTECH BIOLOGICS PLC 1992-08-25 → 1996-07-01
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Deloitte LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The financial statements have been prepared on a going concern basis which the directors believe to be appropriate for the following reasons. The directors have a reasonable expectation that the Company has adequate resources to continue its operational existence for the period twelve months from the date of these accounts based on a forecasting exercise performed, covering the same period.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 33 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| COOP, Richard Paul | Secretary | 2024-04-26 | — | — |
| GEIER-CIBIN, Ralf Manfred | Director | 2018-07-16 | Aug 1962 | German |
| SCHWALLER, Johann Claude | Director | 2024-05-01 | Feb 1993 | French |
| WRANKMORE, Martin | Director | 2023-11-01 | Mar 1976 | British |
Show 33 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| ANTHONY WILKINSON, Katherine Frances | Secretary | 1996-06-28 | 2001-02-13 |
| DWYER, Daniel John | Nominee Secretary | 1992-08-25 | 1992-08-25 |
| KENNEDY, Gerard | Secretary | 2003-07-31 | 2024-04-26 |
| SLATER, John Andrew Duncan | Secretary | 1992-08-25 | 1996-06-28 |
| SYMES, Judith Ann | Secretary | 1996-06-28 | 2003-07-31 |
| ALLEN, Peter Vance | Director | 1992-08-25 | 1999-12-31 |
| BAKER, Stephen Martin | Director | 2015-04-02 | 2017-04-28 |
| BATES, Gordon Edward | Director | 2011-10-21 | 2015-04-02 |
| BROWN, Michael Edward | Director | 2015-04-02 | 2020-05-21 |
| CARTER, Nick | Director | 2017-04-25 | 2021-07-01 |
| CHAKRAWERTTI, Sandeepan | Director | 2021-07-01 | 2024-05-01 |
| DOYLE, Betty June | Nominee Director | 1992-08-25 | 1992-08-25 |
| DWYER, Daniel John | Nominee Director | 1992-08-25 | 1992-08-25 |
| FELLNER, Peter John, Dr | Director | 1992-08-25 | 1997-12-02 |
| GARFIELD, Edward | Director | 2017-04-25 | 2024-11-08 |
| GEIER CIBIN, Ralf | Director | 2001-12-20 | 2009-04-30 |
| GEMUEND, Markus | Director | 2001-12-20 | 2004-05-31 |
| HAAG, Toralf, Dr | Director | 2005-08-30 | 2016-03-15 |
| HERGET, Alexander | Director | 2020-05-21 | 2023-10-31 |
| IMWINKELRIED, Rene, Dr | Director | 2003-06-20 | 2004-08-27 |
| KLEMENT, Gerhard Franz | Director | 2004-08-10 | 2005-08-01 |
| KUTZER, Stephan, Dr | Director | 2005-08-01 | 2014-07-01 |
| MANUEL, Johan Pieter | Director | 1996-06-28 | 1997-09-30 |
| MARKETZ, Herbert, Doctor | Director | 1996-06-28 | 1999-11-12 |
| NICHOLLS, Peter Geoffrey | Director | 1994-10-03 | 1996-06-28 |
| OPRANDI, Peter | Director | 2009-04-30 | 2015-04-02 |
| ROBINSON, Edward Raymond | Director | 1997-10-10 | 2000-09-01 |
| ROSS, Iain Gladstone | Director | 1992-08-25 | 1995-10-31 |
| RUPP, Richard Helmut | Director | 2000-04-05 | 2002-05-09 |
| SAVITZKY, Rodolfo | Director | 2015-04-02 | 2018-07-16 |
| SHOTT, Ian Dermot | Director | 1996-06-28 | 1998-07-08 |
| STURGE, Simon John | Director | 1995-11-01 | 1997-10-10 |
| WAIBEL, Roland Michael, Dr | Director | 2000-04-05 | 2005-08-30 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Lonza Group Uk Ltd | Corporate entity | Shares 75–100% | 2016-04-06 | Active |
Filing timeline
Last 20 of 176 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-08-18 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-06-17 | AA | accounts | Accounts with accounts type full | |
| 2024-11-11 | TM01 | officers | Termination director company with name termination date | |
| 2024-08-22 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-08-22 | CH01 | officers | Change person director company with change date | |
| 2024-08-22 | CH01 | officers | Change person director company with change date | |
| 2024-08-21 | CH01 | officers | Change person director company with change date | |
| 2024-07-11 | AA | accounts | Accounts with accounts type full | |
| 2024-06-13 | AP01 | officers | Appoint person director company with name date | |
| 2024-06-12 | TM01 | officers | Termination director company with name termination date | |
| 2024-04-26 | AP03 | officers | Appoint person secretary company with name date | |
| 2024-04-26 | TM02 | officers | Termination secretary company with name termination date | |
| 2023-11-23 | AP01 | officers | Appoint person director company with name date | |
| 2023-11-22 | TM01 | officers | Termination director company with name termination date | |
| 2023-10-05 | AA | accounts | Accounts with accounts type full | |
| 2023-08-18 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-02-13 | AA | accounts | Accounts with accounts type full | |
| 2022-08-12 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-10-04 | AA | accounts | Accounts with accounts type full | |
| 2021-08-11 | CS01 | confirmation-statement | Confirmation statement with no updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 1
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.